Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Levi, Christopher
ACTRN12618000602224: Modafinil In Debilitating Fatigue After Stroke 2 (MIDAS 2)	Recruiting	3	300			The Florey Institute of Neuroscience and Mental Health (The Florey), Greater Building Society	Post Stroke Fatigue
NCT06153693: Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension	Active, not recruiting	3	1083	Europe, Canada, US, RoW	Placebo, lorundrostat Dose 1, lorundrostat Dose 2	Mineralys Therapeutics Inc.	Hypertension	12/24	02/25
ACTRN12609000673246: Dextran in Carotid Endarterectomy Trial	Recruiting	2	1412			National Stroke Research Institute and John Hunter Health	Carotid Endarterectomy and Thromboembolism